Results 51 to 60 of about 9,880,911 (259)
Clinical Studies Target Fewer Complications, Better Outcomes for Vascular Surgery [PDF]
, 2017 Two studies at the Jefferson Vascular Center (JVC) are assessing innovative methods to reduce risk of complications — and increase positive outcomes — for vascular surgery patients. Here, Paul DiMuzio, MD, FACS, William M. Measey Professor of Surgery and
core +1 more source
The utility of home-practice in mindfulness-based group interventions: a systematic review [PDF]
, 2016 A growing body of research supports the efficacy of mindfulness-based interventions (MBIs). MBIs consider home-practice as essential to increasing the therapeutic effects of the treatment.
Ana Baumann (3552509) +4 more
core +6 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács +8 more
wiley +1 more source
Current regulatory requirements for clinical trials of viral vaccines
Биопрепараты: Профилактика, диагностика, лечение, 2023 Scientific relevance. In recent years, the development of various vaccines based on novel platforms has underscored the significance of updating regulatory requirements for vaccines.
A. A. Soldatov +3 more
doaj +1 more source
Security oriented e-infrastructures supporting neurological research and clinical trials [PDF]
, 2007 The neurological and wider clinical domains stand to gain greatly from the vision of the grid in providing seamless yet secure access to distributed, heterogeneous computational resources and data sets.
Ajayi, O. +3 more
core +3 more sources
Current regulatory approaches for accessing potential COVID-19 therapies
Journal of Pharmaceutical Policy and Practice, 2020 This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials.
Vesa Halimi +6 more
doaj +1 more source
Methodological Approaches to Studying Fatal Adverse Drug Reactions
Безопасность и риск фармакотерапии, 2022 Serious adverse drug reactions (ADRs) to medicinal products can cause death. It is an immediate challenge for modern medicine to prevent the possibility of this outcome and to improve the safety of pharmacotherapy.
I. L. Asetskaya +2 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait +23 more
wiley +1 more source
Romanian Journal of Laboratory Medicine, 2018 Introduction: Several landmark studies, which enrolled heart failure (HF) patients who were ambulatory at the time of inclusion, identified iron deficiency (ID) as an important therapeutic target: intravenous iron administration with ferric ...
Antohi Elena Laura +10 more
doaj +1 more source
Telemedicine infectious diseases consultations and clinical outcomes: A systematic review [PDF]
, 2019 Background: Telemedicine use is increasing in many specialties, but its impact on clinical outcomes in infectious diseases has not been systematically reviewed.
Burnham, Jason P +3 more
core +2 more sources